GPC3 and hepatocellular carcinoma: Chu et al. developed a GPC3-based immunomagnetic fluorescent system (C6/MMSN-GPC3), which improved the capture efficiency by 83.3–350% and isolated CTCs from one early-stage HCC patient, indicating its potential for early diagnosis [72].